Abstract
India is considered to be an intermediate area with respect to the prevalence of chronic hepatitis B virus (CHBV) infection. Although CHBV prevalence in the United States is low, a growing incidence of this condition has been reported there, especially in Asian Americans. Recent studies from India have highlighted the fact that a significant proportion of CHBV-infected patients with normal alanine amino-transferase levels have high viremia and significant histologic damage. Studies focusing on Indian Americans are lacking. This article reviews the epidemiology, natural history, and treatment of hepatitis B in India and Indian Americans.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
